Journal Article Summary

The article investigates the use of topical calcineurin inhibitors as an adjunctive treatment for fungal keratitis, a serious eye infection that can lead to poor visual outcomes. Fungal keratitis is particularly challenging because, while antifungal medications can eliminate the infection, they do not always prevent significant corneal damage and scarring caused by inflammation. The study aims to gather insights from cornea specialists on their current practices and opinions regarding the potential benefits of these medications in managing the inflammatory response associated with fungal infections.

To conduct the study, researchers distributed an online survey to cornea specialists, gathering responses from 135 participants, primarily from the United States and India. The survey revealed that a majority of specialists (70%) do not prescribe topical calcineurin inhibitors, with only 23% using them occasionally. However, many respondents believe that higher concentrations of these inhibitors could provide significant anti-inflammatory effects and potentially improve visual acuity by nearly one line on the vision scale when used alongside antifungal treatments. The findings indicate a general belief in the potential benefits of these medications, despite their limited current use in practice.

The study has several limitations, including a small sample size and a focus on specialists, which may not fully represent broader clinical practices. There is also a geographic bias, as most respondents are from the U.S. and India, which may affect the generalizability of the results. Patients and caregivers should discuss the potential use of topical calcineurin inhibitors with their healthcare providers, especially if they are dealing with fungal keratitis, to understand the risks and benefits of this treatment approach. Further clinical trials are needed to establish definitive dosing recommendations and assess the efficacy of these medications in improving outcomes for patients with fungal keratitis.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Christy Josephine, Prathikanti Vishwanath, Abdelrahmen Sarah, Pula Douglas, Rose-Nussbaumer Jennifer, Prajna N. Venkatesh, Lietman Thomas M., Seitzman Gerami D.. Adjunctive Topical Calcineurin Inhibitors During the Treatment of Fungal Keratitis: Practice Patterns and Opinions. Cornea 2025. DOI: 10.1097/ICO.0000000000003934. PMID: 40757929. PMCID: PMC13158013.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]